MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
232.08%
Quick Ratio
229.18%
Cash Ratio
74.20%
Debt to Asset Ratio
181.44%
Unit: Thousand (K) dollars
Assets Breakdown
Short-term investments
Cash and cash equivalents
Trade receivables
Others
Liabilities Breakdown
Accumulated deficit
Additional paid-in capital
Secured term loan
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
154,972
171,591
89,736
84,078
Restricted cash
479
854
201
579
Short-term investments
197,601
66,809
185,011
128,795
Trade receivables
110,757
109,272
106,818
91,325
Inventory, net
6,056
5,985
5,398
5,232
Prepaid expenses and other current assets
14,818
19,114
17,182
16,502
Current assets held for sale-Disposal Group Heldforsale Not Discontinued Operations
-
-
-
29,173
Total current assets
484,683
373,625
404,346
355,684
Long-term inventory, net
31,945
28,176
23,990
23,390
Property and equipment, net
9,058
9,368
8,783
8,396
Long-term investments
0
20,569
61,164
39,669
Right of use assets, net
12,608
13,617
10,203
10,840
Other assets
19,557
19,697
5,672
4,387
Non-current assets held for sale-Disposal Group Heldforsale Not Discontinued Operations
-
-
-
4,058
Total assets
557,851
465,052
514,158
446,424
Accounts payable
11,459
10,958
15,826
5,567
Accrued expenses
121,895
119,398
126,413
118,778
Share-based liability
16,360
16,216
13,743
-
Operating lease liabilities
1,912
1,858
317
348
Finance lease liabilities
1,092
1,235
1,312
1,435
Royalty financing obligations
43,808
40,317
38,455
37,686
Current liabilities held for sale-Disposal Group Heldforsale Not Discontinued Operations
-
-
-
26,423
Deferred revenue
12,320
5,409
-
-
Total current liabilities
208,846
195,391
196,066
190,237
Operating lease liabilities
10,603
11,122
8,571
8,425
Finance lease liabilities
849
1,173
1,441
1,742
Royalty financing obligations
382,981
407,181
427,233
439,107
Secured term loan
395,400
395,197
0
194,366
Non-current liabilities held for sale-Disposal Group Heldforsale Not Discontinued Operations
-
-
-
436
Deferred revenue
13,461
8,831
-
-
Total liabilities
1,012,140
1,018,895
633,311
834,313
Common stock, 0.01 par value shares authorized - 450,000 shares issued and outstanding 255,265 at june30, 2026 and 213,060 at december31, 2025
2,553
2,540
2,131
2,105
Additional paid-in capital
1,693,282
1,671,976
1,384,857
1,360,890
Accumulated other comprehensive (loss) income
-528
-368
38
1,140
Accumulated deficit
-2,149,596
-2,227,991
-1,506,179
-1,752,024
Total stockholders deficit
-454,289
-553,843
-119,153
-387,889
Total liabilities and stockholders deficit
557,851
465,052
514,158
446,424
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Short-term investments
$197,601K
(14.88%↑ Y/Y)
Cash and cash
equivalents
$154,972K
(76.04%↑ Y/Y)
Trade receivables
$110,757K
(21.47%↑ Y/Y)
Prepaid expenses and
other current assets
$14,818K
(18.16%↑ Y/Y)
Inventory, net
$6,056K
(20.06%↑ Y/Y)
Restricted cash
$479K
(-2.64%↓ Y/Y)
Total current assets
$484,683K
(21.64%↑ Y/Y)
Long-term inventory, net
$31,945K
(43.86%↑ Y/Y)
Other assets
$19,557K
(444.46%↑ Y/Y)
Right of use assets,
net
$12,608K
(9.20%↑ Y/Y)
Property and equipment,
net
$9,058K
(7.11%↑ Y/Y)
Total assets
$557,851K
(22.02%↑ Y/Y)
Accumulated deficit
-$2,149,596K
(-21.80%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$528K
(-132.08%↓ Y/Y)
Total liabilities and
stockholders deficit
$557,851K
(22.02%↑ Y/Y)
Total stockholders
deficit
-$454,289K
(-7.76%↓ Y/Y)
Additional paid-in capital
$1,693,282K
(26.40%↑ Y/Y)
Common stock, 0.01 par
value shares...
$2,553K
(21.63%↑ Y/Y)
Total liabilities
$1,012,140K
(15.18%↑ Y/Y)
Secured term loan
$395,400K
(62.85%↑ Y/Y)
Royalty financing
obligations
$382,981K
(-14.48%↓ Y/Y)
Total current
liabilities
$208,846K
(17.89%↑ Y/Y)
Deferred revenue
$13,461K
Operating lease
liabilities
$10,603K
(24.90%↑ Y/Y)
Finance lease
liabilities
$849K
(-58.44%↓ Y/Y)
Accrued expenses
$121,895K
(13.80%↑ Y/Y)
Royalty financing
obligations
$43,808K
(22.57%↑ Y/Y)
Share-based liability
$16,360K
Deferred revenue
$12,320K
Accounts payable
$11,459K
(33.41%↑ Y/Y)
Operating lease
liabilities
$1,912K
(387.76%↑ Y/Y)
Finance lease
liabilities
$1,092K
(-32.43%↓ Y/Y)
Buy us a coffee
BIOCRYST PHARMACEUTICALS INC (BCRX)
BIOCRYST PHARMACEUTICALS INC (BCRX)